This inventor holds 19 USPTO granted patents and 13 published patent applications, plus 7 CIPO patents and 15 EPO patents. Top assignees: Pari Pharma Gmbh, Patara Pharma, LLC, Polyphor Ag. Active years: 2010-2023.
Location History:
- München, DE (2010 - 2015)
- Munich, DE (2012 - 2023)
Company Filing History:
7 out of 53 
4 out of 4 
3 out of 35 
Years Active: 2010-2023
Title: Manfred Keller: Innovator in Pharmaceutical Aerosols
Introduction
Manfred Keller, based in Munich, Germany, is a prominent inventor known for his contributions to the field of pharmaceutical aerosols, with a total of 19 patents to his name. His innovative work focuses on developing advanced therapeutic solutions for pulmonary diseases, making significant strides in improving treatment methods.
Latest Patents
One of Keller's latest patents is titled "Beta-hairpin peptidomimetic with elastase inhibitory activity and aerosol dosage forms thereof." This invention encompasses pharmaceutical aerosols comprising a β-hairpin peptidomimetic, namely cyclo(-OctG-Glu-Thr-Ala-Ser-Ile-Pro-Pro-Gln-Lys-Tyr-Pro-Pro-), or its pharmaceutically acceptable salts. The invention demonstrates inhibitory activity against human neutrophil elastase, making it a valuable tool in the prevention, management, or treatment of various pulmonary diseases. These diseases include alpha-1 antitrypsin deficiency (AATD), cystic fibrosis (CF), non-cystic fibrosis bronchiactasis (NCFB), and chronic obstructive pulmonary disease (COPD), among others. The patent further discusses the formulation of solid or liquid pharmaceutical compositions and kits for the convenient preparation and administration of these aerosols.
Career Highlights
Throughout his career, Manfred Keller has worked with several reputable companies, notably Pari Pharma GmbH and Patara Pharma, LLC. His expertise in pharmaceutical innovation and aerosol technology has positioned him as a key player in the research and development of effective medication delivery systems tailored for respiratory conditions.
Collaborations
Keller has collaborated with notable professionals in the field, including William Gerhart and Ahmet Tutuncu. These collaborations have bolstered the innovative environment surrounding his work, leading to impactful advancements in therapeutic approaches for pulmonary diseases.
Conclusion
With a focus on improving patient outcomes through innovative pharmaceutical solutions, Manfred Keller has established himself as a notable inventor within the realm of aerosol therapies. His significant contributions, marked by numerous patents, continue to shape the landscape of treatments for respiratory diseases, promising a future of enhanced care for patients worldwide.